title: The BRAF V600K mutation is more frequent than the BRAF V600E mutation in melanoma in situ of lentigo maligna type.
authors.affiliation: Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
authors.forename: Elke
authors.initials: E
authors.lastname: Stadelmeyer
authors.affiliation: Institute of Human Genetics, Medical University of Graz, Graz, Austria.
authors.forename: Ellen
authors.initials: E
authors.lastname: Heitzer
authors.affiliation: Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
authors.forename: Margit
authors.initials: M
authors.lastname: Resel
authors.affiliation: Research Unit for Dermatopathology, Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Cerroni
authors.affiliation: Research Unit for Photodermatology, Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria. Electronic address: peter.wolf@medunigraz.at.
authors.forename: Peter
authors.initials: P
authors.lastname: Wolf
authors.affiliation: Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Electronic address: nadia.dandachi@medunigraz.at.
authors.forename: Nadia
authors.initials: N
authors.lastname: Dandachi
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D018327:Hutchinson's Melanotic Freckle / Q000453:epidemiology / Q000235:genetics*; D008297:Male; D008545:Melanoma / Q000453:epidemiology / Q000235:genetics*; D008875:Middle Aged; D017354:Point Mutation; D015995:Prevalence; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D012878:Skin Neoplasms / Q000453:epidemiology / Q000235:genetics*
chemical_list: C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf
references.citation: J Am Acad Dermatol. 1995 Dec;33(6):923-36; quiz 937-40
references.pmid: 7490362
references.citation: N Engl J Med. 2012 Feb 23;366(8):707-14
references.pmid: 22356324
references.citation: PLoS Med. 2008 Jun 3;5(6):e120
references.pmid: 18532874
references.citation: Nat Genet. 2003 Jan;33(1):19-20
references.pmid: 12447372
references.citation: Clin Cancer Res. 2003 Dec 15;9(17):6483-8
references.pmid: 14695152
references.citation: J Natl Cancer Inst. 2003 Dec 17;95(24):1878-90
references.pmid: 14679157
references.citation: J Invest Dermatol. 2005 Sep;125(3):575-9
references.pmid: 16117801
references.citation: J Invest Dermatol. 2010 Jan;130(1):241-8
references.pmid: 19571821
references.citation: Clin Cancer Res. 2006 Aug 1;12(15):4499-505
references.pmid: 16899595
references.citation: J Invest Dermatol. 2004 Nov;123(5):990-2
references.pmid: 15482489
references.citation: J Invest Dermatol. 2004 Jul;123(1):177-83
references.pmid: 15191558
references.citation: Melanoma Res. 2008 Feb;18(1):29-35
references.pmid: 18227705
references.citation: J Invest Dermatol. 2006 Sep;126(9):2111-8
references.pmid: 16691193
references.citation: J Mol Diagn. 2007 Sep;9(4):464-71
references.pmid: 17690212
references.citation: J Invest Dermatol. 2013 Apr;133(4):1027-33
references.pmid: 23096702
references.citation: Melanoma Res. 2006 Aug;16(4):267-73
references.pmid: 16845322
references.citation: J Invest Dermatol. 2006 Aug;126(8):1915-7
references.pmid: 16557238
references.citation: Oncology. 2004;66(5):411-9
references.pmid: 15331929
references.citation: Clin Cancer Res. 2012 Jun 15;18(12):3242-9
references.pmid: 22535154
references.citation: PLoS One. 2007 Feb 21;2(2):e236
references.pmid: 17311103
references.citation: J Pathol. 2011 Jan;223(2):241-50
references.pmid: 21125678